Pilot study of the Korean national breast implant registry: Experiences and lessons learned

• Published in: Journal of plastic, reconstructive & aesthetic surgery reconstructive & aesthetic surgery, 2022-06, Vol.75 (6), p.1833-1841
• Main Authors: Song, W.J., Kang, S.G., Seo, B.M.F., Choi, N.K., Lee, J.H.
• Format: Article
• Language: English
• Subjects: Breast Implantation - methods; Breast implants; Breast Implants - adverse effects; Female; Humans; Mammaplasty; Patient Safety; Pilot Projects; Postoperative Complications; Registries; Republic of Korea
• ISSN: 1748-6815; 1878-0539
• DOI: 10.1016/j.bjps.2022.01.024

To improve the safety and early detection of unexpected breast implant-related complications, the Korean Breast Implant Registry (K-BIR) was launched in 2020 in cooperation with the Korean Society of Plastic and Reconstructive Surgeons and the Korean Ministry of Food and Drug Safety, and a pilot study was conducted. This article provides an overview of our pilot study and experiences of the K-BIR. The dataset to be used in the pilot form of K-BIR was constructed by holding online surveys and meetings focusing on the global breast device registry's minimum dataset. A pilot study was implemented from April 1, 2020, to July 31, 2020, with six university teaching hospitals and four private clinics. During the pilot study period, 325 patients, 451 procedures, and 366 implants were entered into the K-BIR. The most common procedure registered was augmentation mammaplasty (30%) for cosmetic indications, followed by direct-to-implant breast reconstruction (27%). Smooth silicone implant was the most common type (73%) of implant used. A feedback survey after the pilot study included questions about the registration rate compared with an actual procedure, entry time, reasons for difficulty in entry, and additional data needed. The continuous maintenance and development of K-BIR will require an effective dataset, a strengthened legal system for an opt-out registry and personal data protection, various incentives for increasing participation rates, and an electronic platform that patients, manufacturers, and clinicians can easily access. K-BIR has the potential to provide quality assurance and outcomes for research and post-market surveillance systems for breast implants as well as methods for enhancing patient safety.